Summit Therapeutics Inc (NASDAQ:SMMT) traded at $25.0 at close of the session on Friday, July 11 and made a downward move of -3.40% on its previous day’s price. Looking at the stock we see that its previous close was $25.88 and the beta (5Y monthly)
Summit Therapeutics Inc (NASDAQ:SMMT) shares, rose in value on Wednesday, July 09, with the stock price up by 7.61% to the previous day’s close as strong demand from buyers drove the stock to $24.74. Actively observing the price movement in the last trading, the stock
The trading price of Summit Therapeutics Inc (NASDAQ:SMMT) closed higher on Friday, July 03, and closing at $24.55, 8.53% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $20.49 and $25.94. In examining the
Summit Therapeutics Inc (NASDAQ:SMMT) price closed lower on Friday, June 27, and dropping -3.38% below its previous close. A look at the daily price movement shows that the last close reads $21.32, with intraday deals fluctuated between $20.27 and $21.35. The company’s 5Y monthly beta
Summit Therapeutics Inc (NASDAQ:SMMT) traded at $20.16 at close of the session on Friday, June 20 and made an upward move of 20.56% on its previous day’s price. Looking at the stock we see that its previous close was $34.10 and the beta (5Y monthly)
The trading price of Summit Therapeutics Inc (NASDAQ:SMMT) closed lower on Friday, June 13, and closing at $19.78, -1.88% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $19.2 and $20.03. In examining the
Summit Therapeutics Inc (NASDAQ:SMMT) price closed higher on Monday, June 09, and jumping 4.71% above its previous close. A look at the daily price movement shows that the last close reads $20.59. Taking into account the 52-week price action we note that the stock hit
Summit Therapeutics Inc (NASDAQ:SMMT) traded at $20.62 at close of the session on Tuesday, June 03 and made an upward move of 16.33% on its previous day’s price. Summit Therapeutics Inc has a market cap of $15.21 billion and is expected to release its quarterly
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.